parecoxib has been researched along with Chronic Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Qin, J; Su, X; Zhao, J | 1 |
| Guo, J; Yang, Y | 1 |
| Cao, LH; Li, HT; Lin, WQ; Liu, WJ; Zhang, TH; Zhong, ZJ | 1 |
3 other study(ies) available for parecoxib and Chronic Lung Injury
| Article | Year |
|---|---|
Parecoxib mitigates lung ischemia-reperfusion injury in rats by reducing oxidative stress and inflammation and up-regulating HO-1 expression.
Topics: Animals; Heme Oxygenase-1; Inflammation; Isoxazoles; Lung; Lung Injury; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
Parecoxib sodium alleviates ischemia reperfusion-induced pulmonary injury via inhibiting ERK/NF-κB and further activating the HIF-1α pathway.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Hypoxia-Inducible Factor 1, alpha Subunit; Isoxazoles; Lung; Lung Injury; NF-kappa B; Rats; Reperfusion; Reperfusion Injury | 2022 |
Paclitaxel-induced lung injury and its amelioration by parecoxib sodium.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Claudin-4; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Female; Intercellular Adhesion Molecule-1; Isoxazoles; Leukocytes; Lung; Lung Injury; Paclitaxel; Permeability; Rats; Rats, Wistar; Zonula Occludens-1 Protein | 2015 |